Metropolitan Life Insurance CO X Biotech Inc. Transaction History

Metropolitan Life Insurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$10.95 - $16.07 $48,804 - $71,623	-4,457 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$12.95 - $18.24 $57,718 - $81,295	4,457 New	4,457 $57,000
Q3 2021 Mar 30, 2023	BUY	$12.95 - $18.24 $57,718 - $81,295	4,457 New	4,457 $57,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $57,718 - $81,295	4,457 New	4,457 $58,000
Q3 2020 Jun 26, 2023	BUY	$13.97 - $21.16 $63,982 - $96,912	4,580 New	4,580 $87.4 Million
Q2 2020 Jun 26, 2023	BUY	$10.39 - $16.07 $47,586 - $73,600	4,580 New	4,580 $62.8 Million
Q4 2019 Jul 12, 2023	BUY	$8.33 - $19.95 $55,436 - $132,767	6,655 New	6,655 $124 Million

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.